Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Publication year range
1.
Strahlenther Onkol ; 199(11): 973-981, 2023 11.
Article in English | MEDLINE | ID: mdl-37268767

ABSTRACT

PURPOSE: The aim of this study was to evaluate interobserver agreement (IOA) on target volume definition for pancreatic cancer (PACA) within the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Society of Radiation Oncology (DEGRO) and to identify the influence of imaging modalities on the definition of the target volumes. METHODS: Two cases of locally advanced PACA and one local recurrence were selected from a large SBRT database. Delineation was based on either a planning 4D CT with or without (w/wo) IV contrast, w/wo PET/CT, and w/wo diagnostic MRI. Novel compared to other studies, a combination of four metrics was used to integrate several aspects of target volume segmentation: the Dice coefficient (DSC), the Hausdorff distance (HD), the probabilistic distance (PBD), and the volumetric similarity (VS). RESULTS: For all three GTVs, the median DSC was 0.75 (range 0.17-0.95), the median HD 15 (range 3.22-67.11) mm, the median PBD 0.33 (range 0.06-4.86), and the median VS was 0.88 (range 0.31-1). For ITVs and PTVs the results were similar. When comparing the imaging modalities for delineation, the best agreement for the GTV was achieved using PET/CT, and for the ITV and PTV using 4D PET/CT, in treatment position with abdominal compression. CONCLUSION: Overall, there was good GTV agreement (DSC). Combined metrics appeared to allow a more valid detection of interobserver variation. For SBRT, either 4D PET/CT or 3D PET/CT in treatment position with abdominal compression leads to better agreement and should be considered as a very useful imaging modality for the definition of treatment volumes in pancreatic SBRT. Contouring does not appear to be the weakest link in the treatment planning chain of SBRT for PACA.


Subject(s)
Adenocarcinoma , Lung Neoplasms , Pancreatic Neoplasms , Radiosurgery , Humans , Radiosurgery/methods , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/radiotherapy , Adenocarcinoma/surgery , Positron Emission Tomography Computed Tomography , Observer Variation , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/radiotherapy , Pancreatic Neoplasms/surgery , Radiotherapy Planning, Computer-Assisted/methods , Lung Neoplasms/radiotherapy , Pancreatic Neoplasms
2.
Brain Res ; 903(1-2): 62-5, 2001 Jun 08.
Article in English | MEDLINE | ID: mdl-11382388

ABSTRACT

Nicotine-induced catecholamine (CA) secretion and inward ionic currents were inhibited by the opioid antagonist naloxone in cultured bovine chromaffin cells. Naloxone inhibited nicotine-induced CA secretion, as detected by an on-line real-time electrochemical technique, in a dose-dependent manner (IC(50)=29 microM). In voltage-clamped chromaffin cells, nicotine (10 microM) evoked an average peak inward current of -146 pA that was inhibited by low concentrations of naloxone (42% at 0.1 microM). The antagonist also inhibited total charge influx associated with nicotinic receptor activation (53% at 0.1 microM). This provides strong evidence that naloxone modulation of nicotine-induced CA secretion does not involve opioid receptors but results from the direct interaction with the nicotinic receptor itself, which might also be the case for other related opioid compounds.


Subject(s)
Catecholamines/metabolism , Chromaffin Cells/physiology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Animals , Cattle , Chromaffin Cells/cytology , Chromaffin Cells/metabolism , Dose-Response Relationship, Drug , Membrane Potentials/drug effects , Membrane Potentials/physiology , Opioid Peptides/antagonists & inhibitors , Patch-Clamp Techniques , Receptors, Nicotinic/physiology
3.
FEBS Lett ; 418(1-2): 39-42, 1997 Nov 24.
Article in English | MEDLINE | ID: mdl-9414091

ABSTRACT

Nicotine-induced ATP secretion from chromaffin cells was blocked by imipramine and desipramine. This blocking action took place on both, fast and slow, components of ATP secretion. Exposure of chromaffin cells to nicotine (10 microM) for 4 s induced an inward current of about -155 pA. Imipramine and desipramine blocked, in a concentration-dependent manner, both peak inward current and total charge influx in response to nicotine. In addition, imipramine and desipramine partially (40%) blocked depolarization-induced ATP secretion and Ca2+ currents evoked by high K+. This suggests that tricyclic antidepressants block nicotine-induced ATP secretion by acting on two targets: one is the nicotinic receptor itself and the second one are voltage-dependent Ca2+ channels.


Subject(s)
Adenosine Triphosphate/metabolism , Antidepressive Agents, Tricyclic/pharmacology , Chromaffin Cells/physiology , Desipramine/pharmacology , Imipramine/pharmacology , Nicotine/pharmacology , Nicotinic Antagonists , Receptors, Nicotinic/physiology , Animals , Cattle , Cells, Cultured , Chromaffin Cells/cytology , Chromaffin Cells/drug effects , Membrane Potentials/drug effects , Membrane Potentials/physiology , Potassium/pharmacology , Receptors, Nicotinic/drug effects
4.
J Neurochem ; 67(3): 1056-62, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8752112

ABSTRACT

An increase in extracellular Ca2+ concentration from 0.25 to 10 mM enhanced secretion of norepinephrine and epinephrine induced by a high extracellular K+ concentration (75 mM). The increment in extracellular Ca2+ concentration also increased the observed peak inward Ca2+ current in response to long (10-s) depolarizing pulses from a holding potential of -55 mV to +5 mV, from about -26 to -400 pA. However, the total amount of Ca2+ influx into the cell only increased when the extracellular Ca2+ concentration was raised from 0.25 to 1 mM and then remained constant up to 10 mM extracellular Ca2+. ATP is cosecreted with catecholamines following a depolarizing stimulus. Kinetic studies indicated that ATP secretion had two components with time constants, in the presence of 2.5 mM extracellular Ca2+, of approximately 4 and 41 s, being the fast component of secretion produced by the exocytosis of approximately 220 chromaffin granules. The results suggest that, for a given depolarizing stimulus, the size and rate of release for the fast and slow components of secretion are dependent on extracellular Ca2+ concentration.


Subject(s)
Calcium/pharmacology , Chromaffin System/cytology , Chromaffin System/physiology , Adenosine Triphosphate/metabolism , Animals , Calcium/metabolism , Calcium Channels/physiology , Cattle , Cells, Cultured/metabolism , Cells, Cultured/physiology , Electric Conductivity , Electrophysiology , Kinetics , Membrane Potentials/drug effects , Membrane Potentials/physiology
5.
Neurosci Lett ; 191(1-2): 59-62, 1995 May 19.
Article in English | MEDLINE | ID: mdl-7659292

ABSTRACT

We have studied the contribution of N-type voltage-dependent Ca2+ channels to both norepinephrine and epinephrine secretion from bovine chromaffin cells induced by high K+ or nicotine using omega-conotoxin GVIA, a selective blocker of N-type voltage-dependent Ca2+ channels. We found that high K+ (75 mM) induced catecholamine secretion was not affected by exposure of bovine chromaffin cells to omega-conotoxin GVIA (1 microM). However, nicotine-induced both norepinephrine and epinephrine secretion were similarly blocked (about 25%) by omega-conotoxin GVIA (1 microM). This effect could be explained by a potent (about 80%) and reversible blockade of the inward current induced by nicotine receptor activation in bovine chromaffin cells. The results indicate that besides the blockade of N-type voltage-dependent channels, omega-conotoxin GVIA is a potent and reversible blocker of the nicotinic receptor-induced currents in chromaffin cells.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels/metabolism , Catecholamines/metabolism , Chromaffin System/metabolism , Nicotine/antagonists & inhibitors , Peptides/pharmacology , Receptors, Nicotinic/metabolism , Acetylcholine/metabolism , Animals , Calcium Channels/drug effects , Cattle , Chromaffin System/cytology , Chromaffin System/drug effects , Chromatography, High Pressure Liquid , Electrochemistry , Epinephrine/metabolism , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Norepinephrine/metabolism , Patch-Clamp Techniques , Potassium/pharmacology , Receptors, Nicotinic/drug effects , omega-Conotoxin GVIA
6.
FEBS Lett ; 362(1): 15-8, 1995 Mar 27.
Article in English | MEDLINE | ID: mdl-7698345

ABSTRACT

We have studied the contribution of P-type voltage-dependent Ca2+ channels to both catacholamine (CA) and ATP secretion from bovine chromaffin cells induced by high K+ or nicotine using omega-agatoxin IVA, a selective blocker of P-type voltage-dependent Ca2+ channels. We found that high K+ (75 mM) induced the release of about 13% of norepinephrine, 5% epinephrine and 11% ATP, and that omega-agatoxin (100 nM) did not affect this secretion. However, both nicotine-induced CA and ATP secretion were significantly blocked (about 50%) by omega-agatoxin IVA (100 nM). In addition, this toxin also reversibly blocked (about 70%) the inward current induced by nicotine in bovine chromaffin cells. The results suggest that, besides its known action of blocking P-type voltage-dependent channels, omega-agatoxin is a potent and reversible blocker of the nicotinic receptor channel in chromaffin cells, and that this action would explain the blockade of nicotine-induced secretion.


Subject(s)
Adrenal Medulla/drug effects , Calcium Channels/drug effects , Receptors, Nicotinic/drug effects , Spider Venoms/pharmacology , Adenosine Triphosphate/metabolism , Adrenal Medulla/metabolism , Animals , Calcium Channels/metabolism , Cattle , Cells, Cultured , Epinephrine/metabolism , Nicotine/pharmacology , Norepinephrine/metabolism , Patch-Clamp Techniques , Potassium/pharmacology , Receptors, Nicotinic/metabolism , omega-Agatoxin IVA
7.
Int J Clin Lab Res ; 24(4): 213-6, 1994.
Article in English | MEDLINE | ID: mdl-7894046

ABSTRACT

The present study was undertaken to assess the effect of prazosin, a selective postsynaptic alpha 1-adrenergic receptor blocking agent, on normoxic and hypoxic mice, in order to evaluate experimentally its use in the treatment of the excessive erythrocytosis that characterizes chronic mountain sickness. The drug, injected intraperitoneally to adult mice at a dose of 400 micrograms/kg per day, induced a significant depression of the rate or erythropoiesis, as measured by red blood cell 59iron uptake, with a decrease in the hematocrit from the 3rd day. The drug also inhibited the oxygen-dependent secretion of erythropoietin (estimated by the plasma immunoreactive hormone concentration) in hypoxemic mice when injected between 0 and 2 h after initiation of the hypoxic stimulation. When injected daily into mice exposed to intermittent hypobaric hypoxia, prazosin limited the degree of polycythemia or induced a sustained decrease in the hematocrit when polycythemia was already present due to previous exposure. It is postulated that the drug, by reducing the peripheral vascular resistance seen during hypoxia, could increase renal blood flow, thus improving the renal oxygen supply and partially restoring the imbalance between gas supply and demand, which drives erythropoietin formation.


Subject(s)
Adrenergic alpha-1 Receptor Antagonists , Erythropoiesis/drug effects , Hypoxia/drug therapy , Prazosin/pharmacology , Animals , Erythropoiesis/physiology , Erythropoietin/biosynthesis , Female , Hypoxia/physiopathology , Male , Mice , Polycythemia/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...